SABESAN VIJAY 4
4 · Theravance Biopharma, Inc. · Filed Nov 23, 2021
Insider Transaction Report
Form 4
SABESAN VIJAY
SVP, Technical Operations
Transactions
- Tax Payment
Ordinary Shares
2021-11-19$8.36/sh−5,191$43,397→ 235,524 total
Footnotes (1)
- [F1]Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.